Concepedia

Jun Hakamata

JH

Statistics

Publications

5

Citations

80

H-Index

5

Active since

2016

Affiliations

Keio University(Current)

Keio University Hospital

Hakodate Central General Hospital

Jun Hakamata is an author at Keio University specializing in molecular oncology, bioanalysis, and drug discovery.

ORCID

Top concepts

Publications per year

2016–2023

5

Publications

5

Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational Study

Emi Ishikawa, Yuta Yokoyama, Haruna Chishima et al. · Investigational New Drugs · 2023 · 20 citations · Full text

Genetic polymorphisms of enzyme proteins and transporters related to methotrexate response and pharmacokinetics in a Japanese population

Masayuki Hashiguchi, Mikiko Shimizu, Jun Hakamata et al. · Journal of Pharmaceutical Health Care and Sciences · 2016 · 17 citations · Full text

Low-Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin-Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial

Chizuru Sakai, Mototsugu Shimokawa, Hirotoshi Iihara et al. · The Oncologist · 2021 · 17 citations · Full text

Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study

Jun Hakamata, Masayuki Hashiguchi, Yuko Kaneko et al. · Modern Rheumatology · 2017 · 15 citations

Development and validation of a new liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of afatinib, dacomitinib, osimertinib, and the active metabolites of osimertinib in human serum

Emi Ishikawa, Yuta Yokoyama, Haruna Chishima et al. · Journal of Chromatography B · 2022 · 11 citations · Full text

, , +26

1–5 of 5